2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン
2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン 物理性質(zhì)
- 融點(diǎn) :
- 196-198C
- 沸點(diǎn) :
- 427.4±55.0 °C(Predicted)
- 比重(密度) :
- 1.57±0.1 g/cm3(Predicted)
- 貯蔵溫度 :
- Keep in dark place,Sealed in dry,2-8°C
- 溶解性:
- soluble in Methanol
- 外見 :
- powder to crystal
- 酸解離定數(shù)(Pka):
- 2.49±0.10(Predicted)
- 色:
- White to Almost white
- InChI:
- InChI=1S/C13H16FN3O6/c1-5-9(22-6(2)18)10(23-7(3)19)12(21-5)17-4-8(14)11(15)16-13(17)20/h4-5,9-10,12H,1-3H3,(H2,15,16,20)/t5-,9-,10-,12-/m1/s1
- InChIKey:
- NWJBWNIUGNXJGO-YHHSPFQVSA-N
- SMILES:
- C[C@H]1O[C@@H](N2C=C(F)C(N)=NC2=O)[C@H](OC(=O)C)[C@@H]1OC(=O)C
- CAS データベース:
- 161599-46-8(CAS DataBase Reference)
安全性情報(bào)
- リスクと安全性に関する聲明
- 危険有害性情報(bào)のコード(GHS)
| Sフレーズ |
24/25 |
|
|
| HSコード |
29389090 |
|
|
| 絵表示（GHS） |
|
| 注意喚起語 |
警告 |
| 危険有害性情報(bào) |
| コード |
危険有害性情報(bào) |
危険有害性クラス |
區(qū)分 |
注意喚起語 |
シンボル |
P コード |
| H302 |
飲み込むと有害 |
急性毒性、経口 |
4 |
警告 |
|
P264, P270, P301+P312, P330, P501 |
| H315 |
皮膚刺激 |
皮膚腐食性/刺激性 |
2 |
警告 |
|
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
強(qiáng)い眼刺激 |
眼に対する重篤な損傷性/眼刺激 性 |
2A |
警告 |
|
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
呼吸器への刺激のおそれ |
特定標(biāo)的臓器毒性、単回暴露； 気道刺激性 |
3 |
警告 |
|
|
|
| 注意書き |
| P261 |
粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。 |
| P305+P351+P338 |
眼に入った場(chǎng)合：水で數(shù)分間注意深く洗うこと。次にコ ンタクトレンズを著用していて容易に外せる場(chǎng)合は外す こと。その後も洗浄を続けること。 |
|
2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン 価格
もっと(20)
| メーカー |
製品番號(hào) |
製品説明 |
CAS番號(hào) |
包裝 |
価格 |
更新時(shí)間 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01COBQB-1492 |
2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン
2',3'-Di-o-acetyl-5'-deoxy-5-fluorocytidine |
161599-46-8 |
1g |
￥10000 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01MAS090808 |
5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine |
161599-46-8 |
25g |
￥81900 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01COBQB-1492 |
2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン
2',3'-Di-o-acetyl-5'-deoxy-5-fluorocytidine |
161599-46-8 |
5g |
￥17500 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01MAS090808 |
5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine |
161599-46-8 |
100g |
￥215700 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01COBQB-1492 |
2',3'-Di-o-acetyl-5'-deoxy-5-fluorocytidine
2',3'-Di-o-acetyl-5'-deoxy-5-fluorocytidine |
161599-46-8 |
10g |
￥22500 |
2024-03-01 |
購入 |
2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン 化學(xué)特性,用途語,生産方法
外観
白色～ほとんど白色粉末～結(jié)晶
化學(xué)的特性
White to Off-White Solid
定義
ChEBI: A member of the class of cytidines that is a metabolite of the drug capecitabine.
合成
The synthesis of 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-D-cytidine requires two steps, as follows:
(1) Synthesis of 2',3'-Di-O-acetyl-5-fluorocytidine
Under nitrogen atmosphere, add 38.7 g of 2',3',5'-tri-O-acetyl-5-fluorocytidine to 200 mL of 2-methyl-2-oxobutanone. When the temperature is lowered to -5 to 0°C, add 29.5 g of (t-Bu)?Sn(OH)Cl. Maintained at this temperature for 2 hours, then the solvent was removed under reduced pressure. The residue was filtered through silica gel (50 g, 300–400 mesh), eluted with chloroform, and the eluate concentrated to dryness under reduced pressure. A white solid (32.2 g) was obtained, yielding 93.3% with a purity of 98.6%.
(2) Synthesis of 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-D-cytidine
Under nitrogen atmosphere, add 32.2 g 2',3'-di-O-acetyl-5-fluorocytidine and 31.7 g trifluoroacetic acid to 200 mL chloroform. Maintain temperature at -10 to -5°C and add 14.1 g triethylsilane dropwise. After completion of addition, react at this temperature for 3 h. Upon completion of the reaction as indicated by TLC, the residue was washed twice with 300 ml purified water and once with 200 ml saturated sodium bicarbonate solution. After drying and evaporating to dryness, 80 g ethanol was added for recrystallisation. The mixture was cooled to 0–5°C, filtered under vacuum, and dried to yield 29.5 g of product. The yield was 96.1% with a purity of 99.7%.
2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン 上流と下流の製品情報(bào)
原材料
準(zhǔn)備製品
2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン 生産企業(yè)
Global( 474)Suppliers
161599-46-8(2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン)キーワード:
- 161599-46-8
- (2R,3R,4R,5R)-2-(4-aMino-5-fluoro-2-oxopyriMidin-1(2H)-yl)-5-Methyltetrahydrofuran-3,4-diyl diacetate
- 2',3'-di-O-acetyl-5'-deoxy-5-fulurocytidine
- 2,3-diACETATE 5,DEOXY 5,FLUORO CYTIDINE
- Cytidine,5'-deoxy-5-fluoro-, 2',3'-diacetate
- Capecitabine USP IMp.D
- 2',3'-Di-O-carbonyl-5'-deoxy-5-fluorocytidine
- 2 ', 3'-di-O-acetyl -5' - deoxy -5-- fluoro-D-cell pyridine
- 5'-deoxy - diacetyl -5-- fluoro cytidine
- 2,3-DI-O-ACETYL-5-DEOXY-5-FULURO-D-CYTIDINE
- 2',3'-DI-O-ACETYL-5'-DEOXY-5-FLUOROCYTIDIN
- Capecitabine Diacetyl Amino Impurity
- 2',3'-Di-O-acetyl-5'-deoxy-5-fulurocytdine
- 2',3'-Di-o-acetyl-5-fluoro cytidine
- (2R,3R,4S,5R)-2-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl di
- 5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine
- (2R,3R,4S,5R)-4-(acetyloxy)-2-(4-aMino-5-fluoro-2-oxo-1,2-dihydropyriMidin-1-yl)-5-Methyloxolan-3-yl acetate
- 2',3'-Diacetoxyl-5'-deoxy-5-flurocytidine
- Capecitabine Impurity C (EP )
- Capecitabine Impurity 13(Capecitabine EP Impurity C)
- Capecitabine EP Impurity C
- Capecitabine-2
- Capecitabine impurity 4/Capecitabine EP Impurity C/Capecitabine Diacetyl Amino Impurity (USP)/2’,3’-Di-O-acetyl-5’-deoxy-5-fluorocytidine
- [(2R,3R,4R,5R)-4-acetoxy-5-(4-amino-5-fluoro-2-oxo-pyrimidin-1-yl)-2-methyl-tetrahydrofuran-3-yl] acetate
- Capecitabine Diacetyl Amino Imp
- 2',3'-Di-O-acetyl-5'-deoxy-5-F-Cytidine
- 3'-di-O-acetyl-5'-deoxy-5-fulurocytidine
- Capecitabin iMpurity D
- Capecitabine Impurity M(Capecitabine EP Impurity C)
- Capecitabine Imp.D
- 2',3'-Di-O-acetyL
- 2',3'-ジ-O-アセチル-5'-デオキシ-5-フルオロシチジン